Global Artificial T- cell receptors Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

Global Artificial T- cell receptors Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • June 2017 •
  • 190 pages •
  • Report ID: 4959448
The global artificial T-cell receptors market is expected to grow with a CAGR of 44% during the forecast period 2016-2023. The increasing applications of artificial t cell receptors is one of the key factors adding growth in the global artificial T-cell receptors market. the artificial T cell receptors can control affinity of T cell receptors that increase its adoption in application such as drug discovery. Drug discovery is the key application for artificial T-cell receptors market. Personalized medicines have some biological content that allows them to be more effective and have less adverse effects that rises its demand for the treatment of chronic disorders such as cancer, etc. The rising demand for personalized medicine is the key factor that is increasing the demand from drug and discovery application.

Furthermore, increasing prevalence of chronic disorders such as cancer, cardiovascular disorders, etc. and increasing incidences of immunological disorders such as Chronic granulomatous disease is adding meaningful growth in global artificial T cell receptors market. As per WHO, by the end of 2020 there will be approx. $15 million people who are expected to have cancer which is rising by approximately 50%. According to Nation Cancer Institute, the breast cancer is one of the most common cancer in women across the globe. However, stringent government regulation and long duration of trials is restricting the growth of the global artificial T cell receptor market.

Geographically, North America held large market share in terms of revenue in 2016 in global artificial t-cell receptors market,. Rapid rise in research and development (R&D) investment in artificial t-cell receptors by private players and governments across the globe is one of the key factor which is attributing towards the large share of North American market. Moreover, the presence of various key players such as Adaptive Biotech (US), Elli Lilly (US), Pfizer (US), etc. are also adding meaning full growth in the North America artificial T-cell receptors market.

The growth in global artificial t-cell receptors market is also influenced by the presence of major players such as Adaptive Biotech (US), Elli Lilly (US), Juno therapeutics (US), Kitepharma (US), Lonza (Switzerland), Pfizer (US), Thermo Fisher Scientific (US), Precision Bioscience (US), etc. Product launches, Mergers & acquisitions etc. are some crucial strategies adopted by the major players to gain competitive advantage.

The global artificial T-cell receptors market is segmented into application and end user. The application segment is segmented into assay, drug discovery, therapeutics and others. Moreover, the end user segment is further segmented into pharmaceuticals company, biotechnology company, research centers and others. Research center is expected to held largest market share in terms of revenue by the end of 2023. The growing demand for personalized medicine is resulting into the demand for artificial t cell receptors to perform clinical trials.
Country=World Date=201706 Topic=Forecast Publisher=Occams Price=4000